-
2024-518773-33-00
6
2025-08-12
Kidney transplant recipients
-
2024-511131-97-00
4
2025-08-10
Progressive Fibrotic Interstitial Lung Disease
-
2024-517529-26-00
5
2025-08-04
Chronic Inflammatory Demyelinating Polyneuropathy
-
2023-509630-19-00
5
2025-07-31
Esophageal Squamous Cell Carcinoma (ESCC)
-
2024-519059-28-00
5
2025-07-17
Chronic Heart Failure
-
2024-516834-36-00
5
2025-07-08
Locally recurrent unresectable or metastatic TNBC with tumors expressi
-
2024-518678-16-00
6
2025-07-08
Caesarean section, acute postoperative pain
-
2024-513682-40-01
5
2025-07-04
Non-squamous (NSQ), Stage IV or Recurrent Non-small Cell Lung Cancer
-
2023-510294-34-00
5
2025-06-12
small lymphocytic lymphoma (SLL)
-
2024-515868-31-00
5
2025-06-10
Varicella
-
2022-502184-38-00
4
2025-06-06
Rapidly progressive glomerulonephritis
-
2024-516000-41-01
6
2025-06-04
Hypoparathyroidism
-
2023-508196-36-00
4
2025-05-27
Follicular lymphoma
-
2024-519758-35-01
6
2025-05-27
chronic rhinosinusitis with nasal polyps (CRSwNP)
-
2024-517422-25-00
5
2025-05-22
Metastatic Castration-resistant Prostate Cancer (mCRPC)
-
2024-514937-39-00
5
2025-05-20
Dravet Syndrome
-
2024-517513-32-00
5
2025-05-16
Sjögren’s Syndrome
-
2024-519539-41-00
6
2025-05-13
Treatment for vaginal atrophy
-
2024-516605-23-00
5
2025-05-12
relapsed/refractory nodal T cell lymphoma with T follicular helper (TF
-
2023-506460-14-00
5
2025-05-07
Chronic kidney disease (CKD) and hypertension.
-
2024-517229-18-00
11
2025-04-30
Non-ST-Elevation Myocardial Infarction (NSTEMI)
-
2024-517284-23-00
5
2025-04-23
Active Psoriatic Arthritis
-
2024-515279-37-00
5
2025-04-17
Relapsed or Refractory and Lenalidomide exposed Multiple Myeloma
-
2023-508507-20-00
5
2025-04-03
Locally advanced or metastatic conventional chondrosarcoma with an IDH